Glenn C. Worman - 29 Jan 2025 Form 4 Insider Report for Drugs Made In America Acquisition Corp. (DMAA)

Role
CFO
Signature
/s/ Glenn Worman
Issuer symbol
DMAA
Transactions as of
29 Jan 2025
Transactions value $
$0
Form type
4
Filing time
03 Feb 2025, 19:21:52 UTC
Previous filing
10 Jan 2025
Next filing
24 Sep 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction DMAA Ordinary shares Other +100K 100K 29 Jan 2025 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 As of the Transaction Date, the reporting person acquired 100,000 ordinary shares from Drugs Made In America Acquisition LLC, the Issuer's sponsor, for no consideration.